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NUCLEAR CARDIOLOGY-CONVENTIONAL 
IMAGING/PET 
~ Regional Blood Flow, Function, and Metabolism 
in Repetitive Myocardial Stunning 
Marcalo Di Cadi, Polar Pmevsld, Richard Vender Heide, Otto Muzik, 
Teresa Jones, Thomas Mangner. Steven Levine, Joshua Wynne. Wayne 
State Un'wersity, Detroit, Michigan 
It has been suggested that hibernation, a condition of chronic pedusinn- 
COntraction down-regulation with preserved viability, results from recurrent 
episodes of reversible ischemia nd "chronic" postischemic dysfunction. We 
examined the interrelation between flow, metalxdism, and function in an 
acute model of repetitive stunning. Nine dogs underwent four 5 rain balloon 
occlusions of the LAD or circumflex arteries, each separated by 5 rain of 
reperfusion. Regional blood flow (BF), metabolism and function were eval- 
uated 2 hourS after reperfusion in 5 dogs, and 2 hours, 24 hours, and 1 
week post-reperfual0n i 4 dogs, Regional wall motion 0NM) was evaluated 
with 2-D echo and 8F with radiotsbalod micraspheres. Measurements of 
oxidative metabolism (MVO2) and glucose uptake (during hypednsulinemio- 
euglycemic ¢tsmp) were derived with PET imaging. Regional WM was 
severely decreased after the 4 Cycles of ischemia, remained severely im- 
paired 2 hours after repertusion, and normalized after 1 week. Dudng reflow, 
BF in stunned regions was restored to near-normal levels (0.89 • 0,2 vs 
0.95:1:0.2 ml/g/min, P < 0.01). Glucose uptake in stunned regions was 
depressed at 2 hours (73 • 15% of control, P < 0.001) and 24 hours after 
retiow (80 4- 7% of ~ontrel, P = 0.04), but recovered after I week (100 • 26°/= 
of control, P = NS), Similarly, MVO2 in stunned regions was decreased at 2 
hours (84 :E 7% of COntrol, P < 0.001 ) and at 24 hours (8~) :E 6% of COntrol, P 
= 0.02), and recovered 1 week after reperfusion (97 • 3% of COntrol, P = NS). 
Thus, repetitive stunned myocardium demonal~tod a persistent reduction 
of both MVO2 and glucose uptake which recovered as regional wall motion 
improved. The resu~ may have important implk;ations for detecting stunning 
in patients with CAD and further suggest a unique metabolic adaptation in 
"chronic stunning ~, different from that typically seen in hibemalion. 
~ Tc-99m.Labeled Ap4A for Early Gamma 
Scintigrephlc Visualization of Experimental 
Athemscleroti¢ Lesions 
David Elms/oh, Artiom Petrov. Jagat Narula, John Babich, Alan 
J. Fischman, Ban-An Khaw. Massachusetts General Hospital, and 
Northeastern University, Boston, MA 
Substances related to ATP such as diadenosine tetraphosphate (Ap4A) bind 
to purina receptors in vascular smooth muscle o~IL Since proliferating smooth 
muscle cells are an obligatory COmponent of atherosolerotic lesions, T¢-99m- 
Ap4A was used to assess whether puflne receptors are upregutsted and can 
detect atherosclerottc lesions in vive. 
Expedmental alherosclerotio lesions were induced in 3 of 5 NZW rabbits by 
balloon deandothelializatian of abdominal aorta followed by hypedipidemio 
diet for >_ 16 weeks, Two rabbits were used as normal controls. Ap4A was 
radiolabetsd with ~2 mCi of Tc.99m by stannous reduction method, HPLC- 
purified, dried and brought up in saline for Lv. injection. Serial gamma images 
were obtained for the ensuing 3 H and serial blood samples were obtained. 
After the last imaging session, the rabbits were sasrifiP.od, The aortas were 
removed, imaged ex-vivo, and radioactivity COunted, Une¢lulvecal in vivo 
visualization of atharocclerotio lesions in the abdominal aorta was possible 
at 1/2 H in all 3 animals. No activity of Tc~ggm-AINA was seen in abdominal 
aortas of the 2 normal rabbits. The ex vivo images of the aortas correlated 
significantly with in vivo distribution, The %dose/gram uptake of Ap4A was 
as follows: 
An!male in) Visualization of .%...Inject.ed Dass/g ram 
Lesions Abdominal P.o. Thoracic An. 
Alharoaclarotic(3) 3/3 0.08t4-0.006 0.039650.003 p=0.003 
Normal (2) 0/2 0.0095 :E 0.003 0.00~ 4-0.004 p = 0.12 
(p = 0.003) 
The present study demonstrates that targeting of purina receptors is possi- 
ble with Tc-ggm-Ap4A and enables visualization of experimental theroscle- 
rotic lesions within 15-20 minutes after i,v. administration. 
~ T h e  Role of Nitric Oxide (NO) in the Beneficial 
Effects of Chronic Exercise Training on Head 
Failure in Awake Dogs 
Jie Wang, Gang-Hua Yi, Mathias Knecht, Milton Packer, Daniel Bud,,hoff. 
Columbia University College of P&S, New York Ci~, NY 
Physical training (PT) imprOves exam ise tolerance in heart failure (CHF). 
Results of previous studies suggest that these effects may not be related to 
a marked beneficial effect of PT on intrinsic heart properties, On the other 
hand, PT restores the ability of the endothalium to genera:e and liberate NO. 
However, whether the beneficial effects of ET on systemic hemedynamics, 
are mediated by NO is not known, 7 dogs were instrumented tO measure 
LVP and mean aortic pressure (MAP) and for pacing (P). DOgs were cardiac 
paced for 4 weeks and PT on a treadmill (4.4 4- 0.3 km/h, 2 hours/day). 
To assess the contribution of basal NO release to systemic hercodynamics 
following PT, we infused the NO inhibitor nitm-L-arginine (NLA) pdor to and 
after the 4 wks of P plus PT. The results (Table) indicate for the control (pre- 
CHF) state that NLA increased LVSP and MAP significantly with only a small 
increased in LVEDP. It has been shown previously that NLA has no effect 
on these parametam in P induced CHF due to blunted NO production. In 
contrast, PT resulted in normal increases in LVSP and MAP and a markedly 
enhanced increase in LVEDP, unmasking asystemic sign of CHF. 
Pressure Control After P + PT 
(in mmHg) Baseline NLA Baseline NLA 
LVEDP 4.9 -4- 0.6 7.7 5 0.3* 7.6 .~. 0.9 19.34. 3 *+ 
LVSP 13454 167±6' 1374-7 15850* 
MAP 1004-2 12454* 974-2 12855" 
*p < 0.05 v~ Baseline, +p < 0.05 vs Control 
These data suggest that PT maintains NO production in P induced CHF 
and this is an important mediator of the benefits of PT. 
PEDIATRIC CARDIOLOGY/CONGENITAL  HEART 
SURGERY 
~ T h e  PDA Coil Registry: 250 Patient-Years of 
Follow-Up 
Thomas R. Uoyd, Robert H. Beekman iii, John W. Moore, William 
E. Hellenbrand, Ziyed M. Hijazi, Robert J. Sommer, Rolando Zamora, 
Abraham Ruthman for the PDA Coil Investigators. University of Michigan, 
Ann Arbor, MI 
Follow-up information was solicited on patients enrolled in the PDA Coil 
• Registry to fudher characterize the efficacy and safety of COil occlusion for 
patent ductus artedosus (PDA). Ot the 405 follow-up data forms received, 
7 patients did not have COils implanted in their PDA (6 have hod surgical 
ligation) and reported follow-up duration was < 1 week in 27. The remaining 
371 coil occlusion patients have been followed 8.1 ~ 7.8 months (mean :~ SD, 
range 1 week-5 years, median 6.3 months), for a total of 250 patient-years 
of follow-up. 
Efficacy: Spontaneous closure of residual shunts occurred in 82 patients 
and repeat coil procedures were performed in 10 patienm; no patient has had 
surgery for PDA. At most recent follow-up, 3 patients have clinically eVident 
residual PDA shunts, and 19 have shunts by Doppler only. The prevalence 
of residual shunts at follow-up (5.7%, CL95 3.6--8.6°/=) is significantly (p 
< 0.001) leas than the 30.4% L~revalence r ported immediately after coil 
occlusion. Residual shunts were reported in 13/168 (7.7%, CL95 4.1-12,8%) 
patients followed < 6 months and in 8/201 (4%, CL96 1,7-7,8%) patients 
followed • 6 months (p < 0.10). 
Safety: Late death (unrelated to PDA) was r..,'.~oortod in 41405 patients (1%). 
Mild left palmonary artery stenosls was reported in 6 patients (incidence 
2.4/t00 patient-years, CL95 0.9-5.2%). No cases of late coil migration, 
hemolysis, ccarctation, infectious Or thrombaemboli¢ complications, or PDA 
recanalization were reported (incidence CL95 0-1.5/100 patient.years]. 
Conclusion: PDA ¢oll occlusion is a Safe and effective procedure. Complete 
occlusion at follow-up was achieved in 94.3%, although 2.7% required repeal 
coil procedures. No clinically significant complications of the prOcedure were 
reported, although the rare patients with mild left pulmonary artery stacosis 
require continued observation. 
Prospective Analysis of HLA Immunogenlclty of 
Cryopreserved Valved AIIogratts Uaecl in 
Pediatric Heart Surgery 
Robert Shoddy, Dixie Hunter, Koran Osbom, Undo Lambert, LuAnn Mininh, 
John Hawkins, Edwin McGough, Thomas Fuller. Univar~lly of Utah, Salt 
Lake City, U~ Primary Children's Medical Center, Salt Lake Ci~ UT 
To determine the immunogenicity oferyoproserved valved allogrefts used in 
pediatric heart surgery, we pmspectlvely measured the frequency of panel 
reactive antibodies (PRA) before, one month, and 3 months after allegraft 
implantation i  9 children (5.4 :E 2.t yearS, mean :1: SE) (diagnoses trun- 
cue adefiosus [4], aortic regurgitation [3], tetralogy of Fallot [1], pulmonary 
stsnosls [1]) and after open heart surgery without allograft implantation in 
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1t a ~  controls (4.0 ~: 1.5 yoars), PRA was detenn~a~ against an 
All blood Ixoducts were iwadiated and leu~f i i temd.  After allograft im~ 
plantation, PRA increased from 3.2.2.7% (before Surgery) to 63.3 :E 12% 
(25 ~ 2 days after slffge~y) and 99.7 • 0.3% (3A ~: 0.3 months a~ter smgepj), 
Use of ddhioglmit~ to mmo~ IgM resulted in a modest decrease in PIRA at 
one m0nth (to 33.2 • 13%) but no change In PRA at 3 months (93,0 ± 3.4%), 
~ n g  inilJaJ PRA is pa~afly tgM but becomss almost exdusively IgG ~ 
3 monlJls. By 3 ~ ,  PRA was fotmd to be spedfic against HLA Class I 
and of h l~ titm. ConT~ pa~enls howed no increase in PRA ovm time: 1.6 =E 
1% (before surge~), 3.2:1:1% (28 + 5 days afl~" sm~je~), and 1.7 :E 1.2% 
(2,7 + 0.3 months after su~oery). We eondude that cm~sen/ed  valved 
allogra/Is in children [r~l_ t',:'+_ a mmked antibody response ~ ino"eaSes to
b'oad panel reac~ within 3 m0nths m'tm surgew. Tlds HLA sensif~a~on 
Im ~ not only for causing delsta~o,s effects on agogr~ funct~n b,t 
~;o tot limiting the future Ol~OrtUn~ of heart Iransldantalio~ in 10~ients who 
recak.e a~m~s. 
Predictors o f  Hypertension In Long Term 
- Sundvor3 of ~ Coarclallon of lhe Aorta 
O~a H. ,Sa~, Ju,a S tmr~.  Becky LM. CareenS, C,h,V,m~ 
E. Sngeler, Albert P. Roc~dni, James H. Moiler. Un /ve~ of A~n~ 
Minnea~ol~s, ~nneso~ 
To evaluate fa~om ~ with the development of syste~¢ hypenen- 
don (HBP) in pts following coarctaSon of the aorta (COA), we eva.a~ed 68 
0perative stm,,k, om of COA repair. From 195£ to 1972, 277 pts suwived COA 
repair at the univ. of MN. Sixty.six pts were lost to fogow-up and ~rz77 
operaSve ~ were randomly selected to ~ in this study. Blood 
pressure was remm+x~ely d e ~  from ~ne firm l )OSt -op~ visit 
(v+) [n~dlan 0.25 yrs post repalr) and the mast reo~rd~ visit (V'Z) (mec~ 
5.9 yrs post repair). Olood presswe w'~s ~ ~ us~ t~e 
random zero meU~ in s6A;e pt~ (vs) [me~ 24.9 ym post.op), i:'ts were 
divided in two Oroups besed on the presence of HOP at thelr most recent vlsit 
(HBP (31) and Nor~HBP Gp). HBP was defined as systolic or d~astol'= blood 
pressure > 95th %~le for age and sex or being treated Wlth HBP medicatio,s. 
N Sex ~ ,SBP Years C~ 
. . . . . . . .  (M/~ . . . . . . .  my1 ~,o...p ao. a,.wo 0rod 
HBP 3~ 25/tl 9.1d:1E6 141~19 P9+16 35'~10 -0.84"1t 
NI.IBP 36 26/6 7.24-5.9 113d~16 2EL4"9 41&16 -8.34-9,6 
P 68 I~ 0.0001 <0.0001 0.87 0.1 0.01 
~Ut~o~h age at opera,on and re~ng annneg grae%~t were 
~mt between m two Oroups. when a, of the above favors were e~e~d 
tn a multiple Iogisl~ mgmssk~ analysis, SPB et V1 was lhe only s i ~  
ix~dictm of HBP at V3 (p = 0.004). Notably, 18 out of 32 I l y~ ive  pad~rds 
bed been hy~ive  at VI, In summary, HBP is a common problem 
fi)llowi~g mpa;." of GOA and occtmed in 32/68 (47%) pls. Pemistence of HBP 
at ~e first po~st-op visit is Ihe most impodant ~ of hypeh'ension at la~ 
f01k~H~p. 
PERIPHERAL VASCULAR 
DISEASE/THROMBOSIS/EMBOLISM- CLINICAL 
~ Revascularizatlon Achieved by Therapeutic 
F.r~ Van ee, e. Oonnh~d Chert. Stwt e , . t~.  N~o,e  Fenam. Jehy 
M. int .  st B i z~ 's  M~t~ C~,  T~ M~ ,~,  Bos~ M~ 
Th~ em~acy ~"merapeut~" a~0enesis to ind, o~ m a ~  re~a~u- 
~za ,  o, a,d to ~mve hewo~ I ~  has ~em ~ 
In ~rhmnt ischemk: models. However Its e~cacy to sig, iflca, dy imp,~ 
~ pedusim at a ~ level has bern q~'~aL  Acco~ngly we 5~st~ 
0atod Um elect of angtogenic d~apy with vas~dar e~othe, al growth favor 
(VEGF) on muscle pedusian in a rabbit ~ of chmnlc hlnd~nb isd~m~ 
In addiUe~ we evaluated the relask)ns~ behveen rmJ~de perfus~ and the 
oU~r parametem m revamdadzatk)n (eoUateral fo.naUm, f01ood pmss,m 
and ~ now). Musde ped.slon was ~sess~d by ~ of cotomd 
ndcrospheros (15 p.m diametor) b"~4~ped in hin~rind~ mt~des f0tiowin0 an in- 
Vacaldiac admlnlsb-alion. Sixteen New Zealand ralddts Lmdem'ent mr, ectlon 
of one femoral mte~y. Ten days lat~" (day 0), IxaseS"ne meassmmmnts of ~alf 
U o o d ~ x ; ~  scm ~c~ter~ ~rma.o.: ~mvasc,W 
Dopraer-wire ana~ of ,iac u~m no~, and ~ an,~s~ of 
tousle pedusion were ~ .  Each animal hen received In~a-E~ VEGF 
(500/zg, n = 8) or vehide (n = 8), followed by the same dose i.v. ~t days 2 and 
4. At ~y  30 all ~ were ~.~d a,d the ~ sac~c~ 
VEGP Group 60.9 =1:5,5 91 +8 4" 6.8* 
Coldrol gl~op 64,1 4-4,4 73J~ 4" 2,5 
% = % of nom~ 5rd~;,,p < 0.81 vs ¢~x~l day 30 and vs all dsy 0. 
I.inear egmssi~ Collateral Bood pmsswe l~ac l~o~d 
analy~; R va l~ fonnatie~ index flow 
T~su~ t ~  0+88* 0.76* 0.81" 
*AIr p ~'~_5_ '~_ for ~kmaJr r~ l~ s~aly.~ < 0.(X)0S. 
"these ins,its show: 1) VEGF~no~ed ang~e.e~ imp,'ov~ 5ss,e pe~- 
fusion; 2) there is a dear ~ Jo .sh ip  between Ihe degree of mvasculadza~n 
achieved and the ~ of ~; .e  pedusk~. "this st.dy demonstr~es 
the Idlysiok)glcal ~¢a~e of in~roveme~ obsmved with g~mth factor. 
Evidence for  the InVacardiovascular 
~ Slate Induced by Aldal  Fibril lation 
Yasushi Abe, J'qoong I~n~ ~ Fubunand, Mcsaham Ohmod. 
Tsuyoshi Sldmona~la~ Kazuald Kumaoai, Takahisa Yamada, 
Shop Sa~ Nodlake Hole ~ of ~ Osaka p r ~  
To evaluato whether the in~vasct~ hypemlov.Unn state would be induced by 
atriaJ llbn~5on (Aq rot Itse~ rather than e~anlc l~eart msea.~e, p~sma ~/e~s 
ot ~ .  thromt~anSU.o.ddn 3 ~m~,L~ _ .  ('rAT) and a~ha~-.p~..~,~ 
inhiidtoPplasmin complexes (PIC) were measmed in consecusve 17 paSents 
Lots) with paroxysmal ~ ~ (PA~). Of the ~7 pts ( ~  = 
t 1/6, 62 ','- 14 y.o.), foLa' h~l ischemtc Iteatt ¢ssease, tlzree had vaMdar Itea~t 
disease, two had ped- or myocant~ one had s~k r, inus ~ and 
IN) ~ 7 I~  had no oq]aniC heart dise~tses, PN was c(mverl~d to 
slnus dW'd~ |SR) by eleeblcal car(5overs~n (n = 5) or spontaneously (n = 
12). The pla.~na D.dimer, TAT and PIC values we, re m~m,red by enzyme 
i n k y  al the end of PAl (End o~ PN) and 24 hours a~r  convemion 
to SR (24 H Ntm). The m~ duration of PN was 4B~ (3-330 hm)+ The 
~u~s were as mow, baow; 
D4f~mer (ng/ml) ..... TAT (ng/ml) PIC (pO/n~ 
End (~ PAf IG0:1:38 8.2+2.,5 0.66~ 0.10 
24 H/~m' 1~-  28 * 3.1 ~: 0.5" 0.b';7 ~ 0.08 
m~an ~= SE, °p < 0.05,vs End of PN 
The D-elmer and TAT values 24 I~  after ¢onvemion from N to SR were 
slgni~anlly lower dWn g~se al the end ol N. ~ ,  the char<jes in 
p~;ma levels of D-Q,m~, TAT. and PIC did not shaw significant dilemrces 
between pts w;th and without o~uan~ heart _d~_  ___ On the oth~ hand, 
none of D-dimm., TAT or PlC vakBs at Iha end of N s~n~andy conelated 
with the ~ of N. These mst~ i rdc~ l~a~ at~l lb~Jon  tor ~lseg 
would coNdb~ to increase ~e ~ ~1o~1 and that the 
"_ant~_ _~on theraW for Paf m~ht be mcon,nended i~ the du~o~ of N 
would be over 3 hour¢ 
~ Soluble Adhesion Molecule P .~Sele~,  Yon 
Wil lebmd Factor md ~ in A~ 
Slrolm: ~ for Eady ~ and 
Grego~ YM. Lip, J01~ Zadl~ Andrew Bann, Safaf Famoqt, Clan -_~,-~-m~_ ~ , 
Gamh Beev~r~ U~Oq~m~emo~ ~ 
a ~ :  Untver~ H~sp~ # ,S~th Max~,  F-~and 
To ~ t e  end~he~ funcUon and ~ 3  ~xmna, Ues ~ 
stroke, we meas~ed levels of m soluble adhe~on molecule P ~  
(B .L~ PJm sym~s; assoda~d v~th e~e~ a~ ~ ac,v~n~r~ 
tion), yon Wigelxand factor (vWf; DAKO; a mad~ of e~lotheSal dysfunction), 
flbdnoOm (CLAUSS) an~ omer haemod~ok~k;~ b d~es (pLasn,a v~os~.  
Amestmke 
fd~nogen (g/I) $.6 =k 0,9 3.04:0.6 t-line p = 0.803 
Plasma ~sctl~y 1.73=1:0+15 1.66=!:0+09 t-te~ p., 0.04 
WCC.(x lo~n.) e~.  2.~ s .~.  1.7a t-t~.p < 0.~1 
BIo~ Pms~ 158.1/IB9.8 130.3/80.6 t-test, bo~h p< 0.00"; 
p,.se~ec~. (nO/n/) 41S (2S~-~8) 212 (lS0-,-'m) p-  o.0o~ 
~( IU~ ~ |56 (126-176),,,, !06 [6~121) p < 0.001 
nman + r,.d. 
